Vimentin contributes to epithelial-mesenchymal transition ancer cell mechanics by mediating cytoskeletal organization and focal adhesion maturation

Oncotarget

Volumn 6, Issue 18, 2015, Pages 15966-15983

  Liu, Ching Yi ^a   Lin, Hsi Hui ^a   Tang, Ming Jer ^a   Wang, Yang Kao ^a,b  

^a NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

^b TAIPEI MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Cell stiffness; Epithelial mesenchymal transition (EMT); Focal adhesions; Microtubule; Vimentin

Indexed keywords

BETA1 INTEGRIN; UVOMORULIN; VIMENTIN;

ARTICLE; BREAST CANCER CELL LINE; CELL CULTURE; CELL EXPANSION; CELL MATURATION; CELL MIGRATION; CELL MOTILITY; CELL POLARITY; CELL PROLIFERATION; CONTROLLED STUDY; CYTOSKELETON; EPITHELIAL MESENCHYMAL TRANSITION; FOCAL ADHESION; HUMAN; HUMAN CELL; PHENOTYPE; PROTEIN DEPLETION; PROTEIN EXPRESSION; REGULATORY MECHANISM; WOUND HEALING; BREAST TUMOR; CELL ADHESION; CELL MOTION; DEFICIENCY; FEMALE; GENE SILENCING; GENETICS; MCF-7 CELL LINE; METABOLISM; MICROTUBULE; PATHOLOGY; PHYSIOLOGY; TUMOR CELL LINE;

BREAST NEOPLASMS; CELL ADHESION; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; CYTOSKELETON; EPITHELIAL-MESENCHYMAL TRANSITION; FEMALE; FOCAL ADHESIONS; GENE KNOCKDOWN TECHNIQUES; HUMANS; MCF-7 CELLS; MICROTUBULES; VIMENTIN;

EID: 84937896619     PISSN: None     EISSN: 19492553     Source Type: Journal    
DOI: 10.18632/oncotarget.3862     Document Type: Article

References (58)

1. Perou CM, Sorlie T, Eisen MB, van de Rijn M, Jeffrey SS, Rees CA, Pollack JR, Ross DT, Johnsen H, Akslen LA, Fluge O, Pergamenschikov A, Williams C, Zhu SX, Lonning PE, Borresen-Dale AL, et al. Molecular portraits of human breast tumours. Nature. 2000; 406:747-752.
2. Weigelt B, Peterse JL and van't Veer LJ. Breast cancer metastasis: markers and models. Nature reviews Cancer. 2005; 5:591-602.
3. Sarrio D, Rodriguez-Pinilla SM, Hardisson D, Cano A, Moreno-Bueno G and Palacios J. Epithelial-mesenchymal transition in breast cancer relates to the basal-like phenotype. Cancer Res. 2008; 68:989-997.
4. Kalluri R and Weinberg RA. The basics of epithelialmesenchymal transition. J Clin Invest. 2009; 119:1420-1428.
5. Thiery JP, Acloque H, Huang RY and Nieto MA. Epithelialmesenchymal transitions in development and disease. Cell. 2009; 139:871-890.
6. Zlobec I and Lugli A. Epithelial mesenchymal transition and tumor budding in aggressive colorectal cancer: tumor budding as oncotarget. Oncotarget. 2010; 1:651-661.
7. Zeisberg M and Neilson EG. Biomarkers for epithelialmesenchymal transitions. J Clin Invest. 2009; 119:1429-1437.
8. Coulombe PA and Wong P. Cytoplasmic intermediate filaments revealed as dynamic and multipurpose scaffolds. Nat Cell Biol. 2004; 6:699-706.
9. Chung BM, Rotty JD and Coulombe PA. Networking galore: intermediate filaments and cell migration. Curr Opin Cell Biol. 2013; 25:600-612.
10. Thompson EW, Newgreen DF and Tarin D. Carcinoma invasion and metastasis: a role for epithelial-mesenchymal transition? Cancer Res. 2005; 65:5991-5995; discussion 5995.
11. Sommers CL, Walker-Jones D, Heckford SE, Worland P, Valverius E, Clark R, McCormick F, Stampfer M, Abularach S and Gelmann EP. Vimentin rather than keratin expression in some hormone-independent breast cancer cell lines and in oncogene-transformed mammary epithelial cells. Cancer Res. 1989; 49:4258-4263.
12. Abba MC, Drake JA, Hawkins KA, Hu Y, Sun H, Notcovich C, Gaddis S, Sahin A, Baggerly K and Aldaz CM. Transcriptomic changes in human breast cancer progression as determined by serial analysis of gene expression. Breast cancer research: BCR. 2004; 6:R499-513.
13. Lahat G, Zhu QS, Huang KL, Wang S, Bolshakov S, Liu J, Torres K, Langley RR, Lazar AJ, Hung MC and Lev D. Vimentin is a novel anti-cancer therapeutic target; insights from in vitro and in vivo mice xenograft studies. PLoS One. 2010; 5:e10105.
14. Satelli A and Li S. Vimentin in cancer and its potential as a molecular target for cancer therapy. Cell Mol Life Sci. 2011; 68:3033-3046.
15. Lehtinen L, Ketola K, Makela R, Mpindi JP, Viitala M, Kallioniemi O and Iljin K. High-throughput RNAi screening for novel modulators of vimentin expression identifies MTHFD2 as a regulator of breast cancer cell migration and invasion. Oncotarget. 2013; 4:48-63.
16. Pawlak G and Helfman DM. Cytoskeletal changes in cell transformation and tumorigenesis. Current opinion in genetics & development. 2001; 11:41-47.
17. Nagano M, Hoshino D, Koshikawa N, Akizawa T and Seiki M. Turnover of focal adhesions and cancer cell migration. Int J Cell Biol. 2012; 2012:310616.
18. Desgrosellier JS and Cheresh DA. Integrins in cancer: biological implications and therapeutic opportunities. Nature reviews Cancer. 2010; 10:9-22.
19. Levental KR, Yu H, Kass L, Lakins JN, Egeblad M, Erler JT, Fong SF, Csiszar K, Giaccia A, Weninger W, Yamauchi M, Gasser DL and Weaver VM. Matrix crosslinking forces tumor progression by enhancing integrin signaling. Cell. 2009; 139:891-906.
20. Wei WC, Lin HH, Shen MR and Tang MJ. Mechanosensing machinery for cells under low substratum rigidity. Am J Physiol Cell Physiol. 2008; 295:C1579-1589.
21. Kanchanawong P, Shtengel G, Pasapera AM, Ramko EB, Davidson MW, Hess HF and Waterman CM. Nanoscale architecture of integrin-based cell adhesions. Nature. 2010; 468:580-584.
22. MacPherson M and Fagerholm SC. Filamin and filaminbinding proteins in integrin-regulation and adhesion. Focus on: "FilaminA is required for vimentin-mediated cell adhesion and spreading". Am J Physiol Cell Physiol. 2010; 298:C206-208.
23. Stossel TP, Condeelis J, Cooley L, Hartwig JH, Noegel A, Schleicher M and Shapiro SS. Filamins as integrators of cell mechanics and signalling. Nat Rev Mol Cell Biol. 2001; 2:138-145.
24. McInroy L and Maatta A. Down-regulation of vimentin expression inhibits carcinoma cell migration and adhesion. Biochem Biophys Res Commun. 2007; 360:109-114.
25. Wang N and Stamenovic D. Contribution of intermediate filaments to cell stiffness, stiffening, and growth. Am J Physiol Cell Physiol. 2000; 279:C188-194.
26. Rathje LS, Nordgren N, Pettersson T, Ronnlund D, Widengren J, Aspenstrom P and Gad AK. Oncogenes induce a vimentin filament collapse mediated by HDAC6 that is linked to cell stiffness. Proc Natl Acad Sci U S A. 2014; 111:1515-1520.
27. Janmey PA, Euteneuer U, Traub P and Schliwa M. Viscoelastic properties of vimentin compared with other filamentous biopolymer networks. J Cell Biol. 1991; 113:155-160.
28. Paszek MJ, Zahir N, Johnson KR, Lakins JN, Rozenberg GI, Gefen A, Reinhart-King CA, Margulies SS, Dembo M, Boettiger D, Hammer DA and Weaver VM. Tensional homeostasis and the malignant phenotype. Cancer Cell. 2005; 8:241-254.
29. Butcher DT, Alliston T and Weaver VM. A tense situation: forcing tumour progression. Nat Rev Cancer. 2009; 9:108-122.
30. Murray ME, Mendez MG and Janmey PA. Substrate stiffness regulates solubility of cellular vimentin. Mol Biol Cell. 2014; 25:87-94.
31. Mendez MG, Restle D and Janmey PA. Vimentin enhances cell elastic behavior and protects against compressive stress. Biophys J. 2014; 107:314-323.
32. Kao J, Salari K, Bocanegra M, Choi YL, Girard L, Gandhi J, Kwei KA, Hernandez-Boussard T, Wang P, Gazdar AF, Minna JD and Pollack JR. Molecular profiling of breast cancer cell lines defines relevant tumor models and provides a resource for cancer gene discovery. PLoS One. 2009; 4:e6146.
33. Yeh YC, Wei WC, Wang YK, Lin SC, Sung JM and Tang MJ. Transforming growth factor-{beta}1 induces Smad3-dependent {beta}1 integrin gene expression in epithelialto- mesenchymal transition during chronic tubulointerstitial fibrosis. Am J Pathol. 2010; 177:1743-1754.
34. Toiyama Y, Yasuda H, Saigusa S, Tanaka K, Inoue Y, Goel A and Kusunoki M. Increased expression of Slug and Vimentin as novel predictive biomarkers for lymph node metastasis and poor prognosis in colorectal cancer. Carcinogenesis. 2013; 34:2548-2557.
35. Liu T, Zhang X, Shang M, Zhang Y, Xia B, Niu M, Liu Y and Pang D. Dysregulated expression of Slug, vimentin, and E-cadherin correlates with poor clinical outcome in patients with basal-like breast cancer. Journal of surgical oncology. 2013; 107:188-194.
36. Vuoriluoto K, Haugen H, Kiviluoto S, Mpindi JP, Nevo J, Gjerdrum C, Tiron C, Lorens JB and Ivaska J. Vimentin regulates EMT induction by Slug and oncogenic H-Ras and migration by governing Axl expression in breast cancer. Oncogene. 2011; 30:1436-1448.
37. Etienne-Manneville S. Microtubules in cell migration. Annu Rev Cell Dev Biol. 2013; 29:471-499.
38. Gotlieb AI, May LM, Subrahmanyan L and Kalnins VI. Distribution of microtubule organizing centers in migrating sheets of endothelial cells. J Cell Biol. 1981; 91:589-594.
39. Gurland G and Gundersen GG. Stable, detyrosinated microtubules function to localize vimentin intermediate filaments in fibroblasts. J Cell Biol. 1995; 131:1275-1290.
40. Prahlad V, Yoon M, Moir RD, Vale RD and Goldman RD. Rapid movements of vimentin on microtubule tracks: kinesin-dependent assembly of intermediate filament networks. J Cell Biol. 1998; 143:159-170.
41. Trevor KT, McGuire JG and Leonova EV. Association of vimentin intermediate filaments with the centrosome. J Cell Sci. 1995; 108:343-356.
42. Liao G and Gundersen GG. Kinesin is a candidate for crossbridging microtubules and intermediate filaments. Selective binding of kinesin to detyrosinated tubulin and vimentin. J Biol Chem. 1998; 273:9797-9803.
43. Green KJ, Bohringer M, Gocken T and Jones JC. Intermediate filament associated proteins. Adv Protein Chem. 2005; 70:143-202.
44. Valencia RG, Walko G, Janda L, Novacek J, Mihailovska E, Reipert S, Andra-Marobela K and Wiche G. Intermediate filament-associated cytolinker plectin 1c destabilizes microtubules in keratinocytes. Mol Biol Cell. 2013; 24:768-784.
45. Wozniak MA, Modzelewska K, Kwong L and Keely PJ. Focal adhesion regulation of cell behavior. Biochim Biophys Acta. 2004; 1692:103-119.
46. Wang N, Tytell JD and Ingber DE. Mechanotransduction at a distance: mechanically coupling the extracellular matrix with the nucleus. Nat Rev Mol Cell Biol. 2009; 10:75-82.
47. Bhattacharya R, Gonzalez AM, Debiase PJ, Trejo HE, Goldman RD, Flitney FW and Jones JC. Recruitment of vimentin to the cell surface by beta3 integrin and plectin mediates adhesion strength. J Cell Sci. 2009; 122:1390-1400.
48. Gregor M, Osmanagic-Myers S, Burgstaller G, Wolfram M, Fischer I, Walko G, Resch GP, Jorgl A, Herrmann H and Wiche G. Mechanosensing through focal adhesionanchored intermediate filaments. FASEB J. 2014; 28:715-729.
49. Mendez MG, Kojima S and Goldman RD. Vimentin induces changes in cell shape, motility, and adhesion during the epithelial to mesenchymal transition. FASEB J. 2010; 24:1838-1851.
50. Esue O, Carson AA, Tseng Y and Wirtz D. A direct interaction between actin and vimentin filaments mediated by the tail domain of vimentin. J Biol Chem. 2006; 281:30393-30399.
51. Havel LS, Kline ER, Salgueiro AM and Marcus AI. Vimentin regulates lung cancer cell adhesion through a VAV2-Rac1 pathway to control focal adhesion kinase activity. Oncogene. 2015; 34:1979-1990.
52. Kreis S, Schonfeld HJ, Melchior C, Steiner B and Kieffer N. The intermediate filament protein vimentin binds specifically to a recombinant integrin alpha2/beta1 cytoplasmic tail complex and co-localizes with native alpha2/beta1 in endothelial cell focal adhesions. Exp Cell Res. 2005; 305:110-121.
53. Ivaska J, Vuoriluoto K, Huovinen T, Izawa I, Inagaki M and Parker PJ. PKCepsilon-mediated phosphorylation of vimentin controls integrin recycling and motility. EMBO J. 2005; 24:3834-3845.
54. Fu J, Wang YK, Yang MT, Desai RA, Yu X, Liu Z and Chen CS. Mechanical regulation of cell function with geometrically modulated elastomeric substrates. Nat Methods. 2010; 7:733-736.
55. Yang MT, Fu J, Wang YK, Desai RA and Chen CS. Assaying stem cell mechanobiology on microfabricated elastomeric substrates with geometrically modulated rigidity. Nat Protoc. 2011; 6:187-213.
56. Subach OM, Patterson GH, Ting LM, Wang Y, Condeelis JS and Verkhusha VV. A photoswitchable orange-to-far-red fluorescent protein, PSmOrange. Nat Methods. 2011; 8:771-777.
57. Caille N, Thoumine O, Tardy Y and Meister JJ. Contribution of the nucleus to the mechanical properties of endothelial cells. J Biomech. 2002; 35:177-187.
58. Chiou YW, Lin HK, Tang MJ, Lin HH and Yeh ML. The influence of physical and physiological cues on atomic force microscopy-based cell stiffness assessment. PLoS One. 2013; 8:e77384.